title: [Potentials of combined non-medication therapy of arterial hypertension associated with ischemic heart disease].
abstract: The objective of the present work was to develop methods and a scientifically sound rationale for the optimization of clinical results of the treatment of patients presenting with arterial hypertension (AH) associated with coronary heart disease (CHD) using red and infra-red (IR) low-intensity laser irradiation. The study included a total of 90 patients of working age (62.2% of men and 37.8% of women) having AH associated with coronary heart disease and abnormal blood lipid spectrum. They were allocated to three groups each comprising 30 patients matched for age, sex, severity of clinical conditions, and character of maintenance medicamental therapy. Patients of group 1 were treated by intravenous blood irradiation with laser light; those in group 2 were given similar treatment in combination with external low-intensity IR laser therapy; patients of group 3 received basal medicamental therapy. The study allowed the clinical value of different variants of low-intensity laser therapy to be assessed as regards efficiency of correction of hypersympaticotony, disturbances of lipid metabolism, and refractoriness to pharmaceutical products as well as improved tolerance of physical exercises, anti-hypertensive, anti-ischemic, and anti-anginal effects, diastolic function, and quality of life as targets of the comprehensive rehabilitative program designed for patients with AH associated with coronary heart disease. An optimized therapeutic modality is proposed for patients presenting with these pathologies based on the application of the low-intensity laser irradiation regime characterized by mutual amplification and complementary action of red and infrared lights.
authors.forename: A A
authors.initials: AA
authors.lastname: Achilov
authors.forename: O D
authors.initials: OD
authors.lastname: Lebedeva
authors.forename: L S
authors.initials: LS
authors.lastname: Bulatetskaia
authors.forename: D U
authors.initials: DU
authors.lastname: Usmonzoda
authors.forename: A S
authors.initials: AS
authors.lastname: Belov
authors.forename: S A
authors.initials: SA
authors.lastname: Kotov
authors.forename: Sh A
authors.initials: ShA
authors.lastname: Achilova
authors.forename: S V
authors.initials: SV
authors.lastname: Rykov
mesh_terms: D003131:Combined Modality Therapy; D057510:Endovascular Procedures / Q000379:methods*; D005260:Female; D006801:Humans; D006973:Hypertension / Q000097:blood / Q000150:complications / Q000188:drug therapy / Q000532:radiotherapy*; D008055:Lipids / Q000097:blood; D028022:Low-Level Light Therapy; D008297:Male; D017202:Myocardial Ischemia / Q000097:blood / Q000150:complications / Q000188:drug therapy / Q000532:radiotherapy*; D016896:Treatment Outcome
chemical_list: D008055:Lipids